Tech Company Inital Public Offerings
AVEO Oncology IPO
AVEO Oncology, operating out of Cambridge, debuted as a public company on 3/12/2010.
Transaction Overview
Company Name
Announced On
3/12/2010
Transaction Type
IPO
Amount
$81,000,000
Proceeds Purpose
Proceeds purposes are detailed in the company statements on file with the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
AVEO Oncology is passionate in our pursuit of improving the lives of patients with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bailey
Chief Financial Officer
Matthew Dallas
Chief Medical Officer
Michael Needle
VP - General Counsel
Karuna Rubin
VP - Operations
Emile Farhan
Browse more venture capital transactions:
Prev: 3/11/2010: betaworks venture capital transaction
Next: 3/12/2010: Sonos venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs